- 全部删除
您的购物车当前为空
Icenticaftor (QBW251) 是一种具有口服活性CFTR 通道增强剂,可用于慢性阻塞性肺疾病 (COPD) 和囊性纤维化研究,对F508del 和G551D CFTR 的EC50分别为 79 和 497 nM。


为众多的药物研发团队赋能,
让新药发现更简单!
Icenticaftor (QBW251) 是一种具有口服活性CFTR 通道增强剂,可用于慢性阻塞性肺疾病 (COPD) 和囊性纤维化研究,对F508del 和G551D CFTR 的EC50分别为 79 和 497 nM。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,630 | In stock | |
| 5 mg | ¥ 3,460 | In stock | |
| 10 mg | ¥ 4,690 | In stock | |
| 25 mg | ¥ 6,960 | In stock | |
| 50 mg | ¥ 9,360 | In stock | |
| 100 mg | ¥ 12,500 | In stock | |
| 200 mg | ¥ 16,900 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 2,750 | In stock |
Icenticaftor 相关产品
| 产品描述 | Icenticaftor (QBW251) is an orally active potentiator of CFTR channel. |
| 靶点活性 | CFTR (G551D):497 nM(EC50), F508del CFTR:79 nM(EC50) |
| 别名 | QBW251 |
| 分子量 | 361.24 |
| 分子式 | C12H13F6N3O3 |
| CAS No. | 1334546-77-8 |
| Smiles | COc1nc(C(=O)NC[C@](C)(O)C(F)(F)F)c(N)cc1C(F)(F)F |
| 密度 | no data available |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 150 mg/mL (415.24 mM), Sonication and heating to 60℃ are recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容